{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:05:50Z","timestamp":1794830750760,"version":"4.9.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/05\/X\/NZ5\/01609"],"award-info":[{"award-number":["2021\/05\/X\/NZ5\/01609"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["MINIATURA -5"],"award-info":[{"award-number":["MINIATURA -5"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cytogfr.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T02:54:36Z","timestamp":1692932076000},"page":"76-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The cytokine trio - visfatin, placental growth factor and fractalkine \u2013 and their role in myocardial infarction with non-obstructive coronary arteries (MINOCA)"],"prefix":"10.1016","volume":"74","author":[{"given":"Aleksandra","family":"Stangret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Dykacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Jab\u0142o\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Weso\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Klimczak-Tomaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Kochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-3313","authenticated-orcid":false,"given":"Mariusz","family":"Tomaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/hrt.2007.131383","article-title":"Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis","volume":"vol. 94","author":"Yilmaz","year":"2008","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib2","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"vol. 38","author":"Agewall","year":"2017","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.cytogfr.2023.08.009_bib3","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/jcm12103586","article-title":"Myocardial infarction with non-obstructive coronary arteries (MINOCA): focus on coronary microvascular dysfunction and genetic susceptibility","volume":"vol. 12","author":"Severino","year":"2023","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib4","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.4244\/EIJ-D-21-00426","article-title":"Myocardial infarction with non-obstructive coronary artery disease","volume":"vol. 17","author":"Lindahl","year":"2021","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/org.6.1.10427","article-title":"Microvascular rarefaction","volume":"vol. 6","author":"Goligorsky","year":"2010","journal-title":"Organogenesis"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"vol. 4","author":"Westermann","year":"2011","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.cytogfr.2023.08.009_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2018.02.010","article-title":"Coronary microembolization and microvascular dysfunction","volume":"vol. 258","author":"Heusch","year":"2018","journal-title":"Int J. Cardiol."},{"issue":"13","key":"10.1016\/j.cytogfr.2023.08.009_bib8","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"vol. 78","author":"Del Buono","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib9","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"vol. 9","author":"Vancheri","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.cytogfr.2023.08.009_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cytogfr.2017.12.001","article-title":"Fractalkine and placental growth factor: a duet of inflammation and angiogenesis in cardiovascular disorders","volume":"vol. 39","author":"Skoda","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib11","first-page":"2444","article-title":"Visfatin: a possible role in cardiovasculo-metabolic disorders","volume":"vol. 9","author":"Dakroub","year":"2020","journal-title":"Cells 2020, Vol. 9, Page 2444"},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib12","first-page":"1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"vol. 14","author":"Samal","year":"1994","journal-title":"Mol. Cell Biol."},{"issue":"49","key":"10.1016\/j.cytogfr.2023.08.009_bib13","doi-asserted-by":"crossref","first-page":"50754","DOI":"10.1074\/jbc.M408388200","article-title":"The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells","volume":"vol. 279","author":"Revollo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2007.09.003","article-title":"Nampt\/PBEF\/Visfatin regulates insulin secretion in \u03b2 cells as a systemic NAD biosynthetic enzyme","volume":"vol. 6","author":"Revollo","year":"2007","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"vol. 49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2005-2248","article-title":"Increased plasma Visfatin concentrations in morbidly obese subjects are reduced after gastric banding","volume":"vol. 91","author":"Haider","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of Visfatin\/Pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"vol. 91","author":"Chen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.cytogfr.2023.08.009_bib18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00125-006-0303-7","article-title":"The release of the adipocytokine Visfatin is regulated by glucose and insulin","volume":"vol. 49","author":"Haider","year":"2006","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ijo.2009.24","article-title":"Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-\u03baB pathway","volume":"vol. 33","author":"Lee","year":"2009","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib20","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"vol. 178","author":"Moschen","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2008.11.024","article-title":"Pre-B cell colony enhancing factor (PBEF)\/Visfatin induces secretion of MCP-1 in human endothelial cells: Role in Visfatin-induced angiogenesis","volume":"vol. 205","author":"Adya","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/dc07-1544","article-title":"Nuclear Factor-\u03baB Induction by Visfatin in human vascular endothelial cellsits role in MMP-2\/9 production and activation","volume":"vol. 31","author":"Adya","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbamcr.2008.01.004","article-title":"Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-\u03baB activation in endothelial cells","volume":"vol. 1783","author":"Kim","year":"2008","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Cell Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI19930","article-title":"Pre\u2013B cell colony\u2013enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis","volume":"vol. 113","author":"Jia","year":"2004","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib25","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1038\/s41598-020-62190-w","article-title":"Visfatin\/eNampt induces endothelial dysfunction in vivo: a role for toll-like receptor 4 and NLRP3 inflammasome","volume":"vol. 10","author":"Romacho","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.preghy.2019.09.022","article-title":"NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia","volume":"vol. 18","author":"Pereira","year":"2019","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12902-019-0452-6","article-title":"The role of the adipocytokines vaspin and Visfatin in vascular endothelial function and insulin resistance in obese children","volume":"vol. 19","author":"Yin","year":"2019","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib28","doi-asserted-by":"crossref","DOI":"10.1515\/BC.2006.015","article-title":"NF-\u03baB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells","volume":"vol. 387","author":"Cramer","year":"2006","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib29","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (vascular endothelial growth factor) inhibitor\u2013associated hypertension and vascular disease","volume":"vol. 71","author":"Pandey","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib30","doi-asserted-by":"crossref","first-page":"L559","DOI":"10.1152\/ajplung.00075.2006","article-title":"Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release","volume":"vol. 292","author":"Mohammed","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"vol. 7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"vol. 44","author":"Falco","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"vol. 33","author":"Semenza","year":"2012","journal-title":"Trends Pharm. Sci."},{"issue":"6617","key":"10.1016\/j.cytogfr.2023.08.009_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"vol. 385","author":"Bazan","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","article-title":"Fractalkine in vascular biology","volume":"vol. 24","author":"Umehara","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1471-4906(01)02051-8","article-title":"Fractalkine and vascular injury","volume":"vol. 22","author":"Umehara","year":"2001","journal-title":"Trends Immunol."},{"issue":"41","key":"10.1016\/j.cytogfr.2023.08.009_bib37","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-\u03b1-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)","volume":"vol. 276","author":"Garton","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/bj20030207","article-title":"Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway","volume":"vol. 373","author":"Chandrasekar","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvm067","article-title":"Activation of fractalkine\/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A\/KDR and reverses hindlimb ischaemia","volume":"vol. 78","author":"Ryu","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.cytogfr.2023.08.009_bib40","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.4049\/jimmunol.164.8.4055","article-title":"Fractalkine-mediated endothelial cell injury by NK cells","volume":"vol. 164","author":"Yoneda","year":"2000","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib41","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db10-0956","article-title":"Fractalkine is a novel human adipochemokine associated with type 2 diabetes","volume":"vol. 60","author":"Shah","year":"2011","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1096\/fasebj.11.5.9141503","article-title":"Vascular development: cellular and molecular regulation","volume":"vol. 11","author":"Beck","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"vol. 12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/Akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"vol. 78","author":"Adya","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2008.12.042","article-title":"Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis","volume":"vol. 379","author":"Bae","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/cells9051315","article-title":"Visfatin Increases VEGF-dependent angiogenesis of endothelial progenitor cells during osteoarthritis progression","volume":"vol. 9","author":"Tsai","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1165\/rcmb.2019-0164OC","article-title":"Direct extracellular NAMPT involvement in pulmonary hypertension and vascular remodeling. transcriptional regulation by SOX and HIF-2\u03b1","volume":"vol. 63","author":"Sun","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib48","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease","volume":"vol. 95","author":"Charo","year":"2004","journal-title":"Circ. Res"},{"issue":"04","key":"10.1016\/j.cytogfr.2023.08.009_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0028-1102914","article-title":"Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells","volume":"vol. 41","author":"Liu","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155193","article-title":"The up-regulation of markers of adipose tissue fibrosis by Visfatin in pre-adipocytes as well as obese children and adolescents","volume":"vol. 134","author":"Ezzati-Mobaser","year":"2020","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib51","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1002\/jcp.30345","article-title":"Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases","volume":"vol. 236","author":"Dakroub","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400244","article-title":"PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors","volume":"vol. 1","author":"Iwamoto","year":"2015","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib53","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","article-title":"Chemokines in vascular dysfunction and remodeling","volume":"vol. 28","author":"Schober","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib54","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1194\/jlr.R500004-JLR200","article-title":"Thematic review series: the immune system and atherogenesis. cytokines affecting endothelial and smooth muscle cells in vascular disease","volume":"vol. 46","author":"Raines","year":"2005","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue","volume":"vol. 113","author":"Guzik","year":"2017","journal-title":"Cardiovasc Res."},{"issue":"20","key":"10.1016\/j.cytogfr.2023.08.009_bib56","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1111\/bph.13705","article-title":"Perivascular adipose tissue inflammation in vascular disease","volume":"vol. 174","author":"Nosalski","year":"2017","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvr221","article-title":"Detrimental effect of fractalkine on myocardial ischaemia and heart failure","volume":"vol. 92","author":"Xuan","year":"2011","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib58","article-title":"CX3CL1 worsens cardiorenal dysfunction and serves as a therapeutic target of canagliflozin for cardiorenal syndrome","volume":"vol. 13","author":"Zheng","year":"2022","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib59","first-page":"322","article-title":"The cardiovascular impact of Visfatin - an inflammation predictor biomarker in metabolic syndrome","volume":"vol. 89","author":"Hognogi","year":"2016","journal-title":"Clujul Med."},{"issue":"21","key":"10.1016\/j.cytogfr.2023.08.009_bib60","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/CIRCULATIONAHA.104.495887","article-title":"Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation","volume":"vol. 111","author":"Khurana","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.ATV.0000251535.30191.60","article-title":"The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions","volume":"vol. 27","author":"Sch\u00e4fer","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2023.08.009_bib62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of Visfatin in macrophages of human unstable carotid and coronary atherosclerosis","volume":"vol. 115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12192-013-0417-z","article-title":"Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36","volume":"vol. 18","author":"Zhou","year":"2013","journal-title":"Cell Stress Chaperon-.-."},{"issue":"51","key":"10.1016\/j.cytogfr.2023.08.009_bib64","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"vol. 277","author":"Kunjathoor","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib65","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/07853890.2010.497767","article-title":"The role of monocytes in atherosclerotic coronary artery disease","volume":"vol. 42","author":"Pamukcu","year":"2010","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2006.10.038","article-title":"Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization","volume":"vol. 196","author":"Pilarczyk","year":"2008","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nm.1852","article-title":"PlGF\u2013MMP-9\u2013expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle","volume":"vol. 14","author":"Gargioli","year":"2008","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib68","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.21.6.923","article-title":"Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions","volume":"vol. 21","author":"Greaves","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease","volume":"vol. 11","author":"Wong","year":"2002","journal-title":"Cardiovasc. Pathol."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1172\/JCI15555","article-title":"Decreased atherosclerosis in CX3CR1\u2013\/\u2013 mice reveals a role for fractalkine in atherogenesis","volume":"vol. 111","author":"Lesnik","year":"2003","journal-title":"J. Clin. Invest"},{"issue":"7","key":"10.1016\/j.cytogfr.2023.08.009_bib71","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.CIR.0000057548.68243.42","article-title":"Decreased atherosclerotic lesion formation in CX3CR1\/Apolipoprotein E double knockout mice","volume":"vol. 107","author":"Combadi\u00e8re","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1253\/circj.CJ-09-0484","article-title":"Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris","volume":"vol. 74","author":"Ikejima","year":"2010","journal-title":"Circ. J."},{"issue":"9","key":"10.1016\/j.cytogfr.2023.08.009_bib73","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1253\/circj.CJ-11-1457","article-title":"Independent roles of monocyte chemoattractant protein-1, regulated on activation, normal T-cell expressed and secreted and fractalkine in the vulnerability of coronary atherosclerotic plaques","volume":"vol. 76","author":"Li","year":"2012","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-021-00654-w","article-title":"Inflammation in plaque erosion and rupture","volume":"vol. 19","author":"Huynh","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib75","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current mechanistic concepts in ischemia and reperfusion injury","volume":"vol. 46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.934279","article-title":"Coronary functional assessment in non-obstructive coronary artery disease: present situation and future direction","volume":"vol. 9","author":"Zhai","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib77","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"vol. 102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib78","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.amjcard.2015.06.011","article-title":"Risk factors and markers for acute myocardial infarction with angiographically normal coronary arteries","volume":"vol. 116","author":"Daniel","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.cytogfr.2023.08.009_bib79","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1373\/clinchem.2018.301085","article-title":"Increased inflammatory activity in patients 3 months after myocardial infarction with nonobstructive coronary arteries","volume":"vol. 65","author":"Hjort","year":"2019","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2023.08.009_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-020-01549-3","article-title":"Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction","volume":"vol. 20","author":"Zheng","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib81","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1681\/ASN.2014080772","article-title":"Placental growth factor as a predictor of cardiovascular events in patients with CKD from the NARA-CKD study","volume":"vol. 26","author":"Matsui","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.cytogfr.2023.08.009_bib82","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/aps.2013.92","article-title":"Chemokines and atherosclerosis: focus on the CX3CL1\/CX3CR1 pathway","volume":"vol. 34","author":"Apostolakis","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib83","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1586\/14779072.2013.833854","article-title":"Coronary microvascular dysfunction in women: an overview of diagnostic strategies","volume":"vol. 11","author":"Kuruvilla","year":"2014","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib84","doi-asserted-by":"crossref","first-page":"H1381","DOI":"10.1152\/ajpheart.00922.2007","article-title":"Placental growth factor (PlGF) is a potent vasodilator of rat and human resistance arteries","volume":"vol. 294","author":"Osol","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"572","key":"10.1016\/j.cytogfr.2023.08.009_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8587","article-title":"Evidence for a protective role of placental growth factor in cardiovascular disease","volume":"vol. 12","author":"Chen","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.cytogfr.2023.08.009_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-019-0817-3","article-title":"Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping","volume":"vol. 21","author":"Lin","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"issue":"17","key":"10.1016\/j.cytogfr.2023.08.009_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013235","article-title":"Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako\u2010Tsubo syndrome","volume":"vol. 8","author":"Gaibazzi","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.cytogfr.2023.08.009_bib88","doi-asserted-by":"crossref","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"vol. 2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cytogfr.2023.08.009_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104569","article-title":"Role of fractalkine in promoting inflammation in sepsis-induced multiple organ dysfunction","volume":"vol. 85","author":"Chen","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"7","key":"10.1016\/j.cytogfr.2023.08.009_bib90","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"vol. 1","author":"Autiero","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cytogfr.2023.08.009_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mi.10.5.3","article-title":"Fractalkine\/CX3CL1: a potential new target for inflammatory diseases","volume":"vol. 10","author":"Jones","year":"2010","journal-title":"Mol. Inter."},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib92","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/epi.27835","article-title":"Epigenetic control of hypoxia inducible factor-1\u03b1-dependent expression of placental growth factor in hypoxic conditions","volume":"vol. 9","author":"Tudisco","year":"2014","journal-title":"Epigenetics"},{"issue":"40","key":"10.1016\/j.cytogfr.2023.08.009_bib93","doi-asserted-by":"crossref","first-page":"25176","DOI":"10.1074\/jbc.272.40.25176","article-title":"Genomic organization of human and mouse genes for vascular endothelial growth factor C","volume":"vol. 272","author":"Chilov","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2023.08.009_bib94","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20080476","article-title":"Regulation of hypoxia-inducible factor-1\u03b1 by NF-\u03baB","volume":"vol. 412","author":"van Uden","year":"2008","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.cytogfr.2023.08.009_bib95","first-page":"1498","article-title":"Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four \u03ba\u03b2-like motifs and of constitutive and inducible forms of NF-\u03baB","volume":"vol. 10","author":"Collart","year":"1990","journal-title":"Mol. Cell Biol."},{"issue":"51","key":"10.1016\/j.cytogfr.2023.08.009_bib96","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-\u03baB: players, pathways, perspectives","volume":"vol. 25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.cytogfr.2023.08.009_bib97","doi-asserted-by":"crossref","first-page":"20570","DOI":"10.1074\/jbc.M110.119495","article-title":"Placenta growth factor-induced early growth response 1 (Egr-1) regulates hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) in endothelial cells","volume":"vol. 285","author":"Patel","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2023.08.009_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvm067","article-title":"Activation of fractalkine\/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A\/KDR and reverses hindlimb ischaemia","volume":"vol. 78","author":"Ryu","year":"2008","journal-title":"Cardiovasc Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2023.08.009_bib99","doi-asserted-by":"crossref","first-page":"H2836","DOI":"10.1152\/ajpheart.00113.2006","article-title":"Fractalkine stimulates angiogenesis by activating the Raf-1\/MEK\/ERK- and PI3K\/Akt\/eNOS-dependent signal pathways","volume":"vol. 291","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.cytogfr.2023.08.009_bib100","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1074\/jbc.M110.165605","article-title":"RACK1 regulates VEGF\/Flt1-mediated cell migration via activation of a PI3K\/Akt pathway","volume":"vol. 286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610123000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610123000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:20:53Z","timestamp":1778520053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610123000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":100,"alternative-id":["S1359610123000527"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2023.08.009","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytokine trio - visfatin, placental growth factor and fractalkine \u2013 and their role in myocardial infarction with non-obstructive coronary arteries (MINOCA)","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}